Opendata, web and dolomites

In-Cytes SIGNED

IN-CYTES A HIGH-DENSITY MICROELECTRODE ARRAY PLATFORM FOR LARGE-SCALE INTRACELLULAR FUNCTIONAL ASSAYS

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 In-Cytes project word cloud

Explore the words cloud of the In-Cytes project. It provides you a very rough idea of what is the project "In-Cytes" about.

quantifying    basic    alzheimer    employment    poor    opportunity    business    enterprise    diseases    connectivity    physiology    spatial    grant    brain    technologies    data    skills    perceived    mxw    cure    cells    thousands    microfabrication    budget    neurodegenerative    platform    unknown    turn    innovative    companies    pharmacy    hardware    preclinical    contrast    platforms    biosystems    multidisciplinary    expertise    overcome    interference    maxwell    resolution    swiss    brand    estimate    associate    barriers    bio    physiological    expert    lacking    throughput    combining    parkinson    minimum    larger    relatively    neurons    drugs    software    continue    disorders    cytes    intracellular    initial    industrial    discovery    engineering    bioassays    envisaged    drug    prototype    innovation    career    featuring    limited    public    small    direct    electrophysiological    either    company    ag    first    neuroscience    salary    recruitment    academic    indirect    visibility    radically    compete    start    nerve    electrophysiology    neural   

Project "In-Cytes" data sheet

The following table provides information about the project.

Coordinator
MAXWELL BIOSYSTEMS AG 

Organization address
address: ALBISRIEDERSTRASSE 253
city: ZURICH
postcode: 8047
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 135˙500 €
 EC max contribution 135˙500 € (100%)
 Programme 1. H2020-EU.2.3.2.2. (Enhancing the innovation capacity of SMEs)
 Code Call H2020-INNOSUP-2019-02
 Funding Scheme CSA
 Starting year 2019
 Duration (year-month-day) from 2019-10-15   to  2020-10-14

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MAXWELL BIOSYSTEMS AG CH (ZURICH) coordinator 135˙500.00

Map

 Project objective

MaxWell Biosystems AG (MxW) is a Swiss public limited company (AG) who developed electrophysiological platforms (hardware-software-bioassays) for basic research and drug testing on nerve cells. MxW’s aim is to develop In-Cytes, a radically innovative electrophysiology platform to assess neural connectivity for preclinical drug discovery for brain diseases. In contrast to the state-of-the-art technologies for quantifying neural connectivity, which either estimate indirect connectivity or feature poor spatial resolution, In-Cytes can measure physiological direct neural intracellular connectivity among thousands of neurons. This directly addresses the industrial need in pharmacy for neural connectivity bioassays, featuring high-throughput and minimum interference with neurons’ physiology for the development of effective drugs to cure neurodegenerative disorders, such as Alzheimer’s and Parkinson’s diseases.

The proposed recruitment of an Innovation Associate will have significant impact on the business opportunities of MxW by bringing in lacking expertise for the development of In-Cytes. The envisaged grant will help to overcome the recruitment barriers of being a relatively unknown, small start-up enterprise that cannot compete with larger companies due to limited visibility, brand awareness, (perceived) career opportunities, salary and recruitment budget.

The development of In-Cytes requires the employment of an academic expert with a multidisciplinary set of skills combining knowledge in neuroscience, microfabrication and data analysis. In turn, the innovation associate will have the opportunity to become an expert in the emerging field of bio-engineering. It is in the interest of the company to continue the employment after the initial year in order to develop the first prototype of In-Cytes into an industrial end product.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IN-CYTES" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "IN-CYTES" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.2.2.)

bsnEA (2020)

Business Support Network – East Anatolia

Read More  

PROBIM (2020)

PRO Business Innovation Moldova

Read More  

SSBI-CRO-KAM5 (2020)

Services in Support for Business and Innovation in Croatia - Key Account Management - SSBI-CRO-KAM5

Read More